Ms. June A Tierney, APRN-BC Clinical Nurse Specialist - Psych/Mental Health, Child & Adolescent Medicare: Medicare Enrolled Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-748-5689 Fax: 203-205-2627 |
Miss Evette Natasha James, APRN Clinical Nurse Specialist - Gerontology Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7129 Fax: 203-749-9006 |
Dr. Andree De Lisser, Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Medicare Enrolled Practice Location: 24 Hospital Ave, Danbury Hospital Psychiatry, Danbury, CT 06810 Phone: 914-907-3127 |
Bernadene Lawrence-phillip, APRN Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-7000 |
Eileen Campbell, APRN Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-739-6548 |
Joann H Ahern, APRN Clinical Nurse Specialist - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 79 Sand Pit Rd, Suite 201, Danbury, CT 06810 Phone: 203-749-5754 Fax: 203-749-5760 |
Carol F Boaz, APRN Clinical Nurse Specialist - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 30 Milestone Rd, Danbury, CT 06810 Phone: 203-702-7400 |
News Archive
Eli Lilly and Company has announced that the U.S. District Court for the Southern District of Indiana today issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling.
Men are more prone to competitive risk taking and violent behavior, so what happens when the number of men is greater than the number of women in a population?
Federal Drug Administration Commissioner Margaret A. Hamburg announced a new "Safe Use" program for drugs on Wednesday.
University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease.
› Verified 1 days ago